T1	Participants 58 91	patients with multivessel disease
T2	Participants 327 364	patients with coronary artery disease
T3	Participants 408 486	patients with multivessel disease suitable for treatment with either procedure
T4	Participants 590 715	Patients with multivessel disease were randomly assigned to an initial treatment strategy of CABG (n = 914) or PTCA (n = 915)
T5	Participants 1669 1749	diabetic patients who were being treated with insulin or oral hypoglycemic agent
T6	Participants 2042 2075	patients with multivessel disease
T7	Participants 2163 2180	treated diabetics
